Evidence map›Paper›PMID 10587517›Full record

ArticleThe Journal of clinical investigation1999

A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells.

H Itoh, P L Beck, N Inoue, R Xavier, D K Podolsky

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Frontiers in nutrition · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Murine guanylate cyclase C regulates colonic injury and inflammation.Journal of immunology (Baltimore, Md. : 1950) · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

H ItohGastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
P L Beck
N Inoue
R Xavier
D K Podolsky
Harvard University Press · USHarvard University · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
TREFOIL FACTORS, GOBLET CELLS AND MUCOSAL INTEGRITYR01DK046906 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI PODOLSKY, DANIEL K · 1994 to 2006
$2.4M
NIDDK NIH HHS DK-46906NIDDK NIH HHS DKJ-43351NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK046906
6 · The paper itself

Abstract

Goblet cells are the major mucus-producing cells of the intestine and are presumed to play an important role in mucosal protection. However, their functional role has not been directly assessed in vivo. In initial studies, a 5' flanking sequence of the murine intestinal trefoil factor (ITF) gene was found to confer goblet cell-specific expression of a transgene. To assess the role of goblet cells in the intestine, we generated transgenic mice in which approximately 60% of goblet cells were ablated by the expression of an attenuated diphtheria toxin (DT) gene driven by the ITF promoter; other cell lineages were unaffected. We administered 2 exogenous agents, dextran sodium sulfate (DSS) and acetic acid, to assess the susceptibility of mITF/DT-A transgenic mice to colonic injury. After oral administration of DSS, 55% of control mice died, whereas DT transgenic mice retained their body weight and less than 5% died. Similarly, 30% of the wild-type mice died after mucosal administration of acetic acid, compared with 3.2% of the transgenic mice. Despite the reduction in goblet-cell number, the total amount of ITF was increased in the mITF/DT-A transgenic mice, indicating inducible compensatory mechanisms. These results suggest that goblet cells contribute to mucosal protection and repair predominantly through production of trefoil peptides.

Indexed as

Muscle ProteinsNeuropeptidesAcetic AcidAnimalsbeta-GalactosidaseBody WeightColonDextran SulfateDiphtheria ToxinGenes, ReporterGoblet CellsGrowth SubstancesHistocytochemistryMiceMice, TransgenicMucin-2Acetic Acidbeta-GalactosidaseDextran SulfateDiphtheria ToxinGrowth SubstancesMuc2 protein, mouseMuc2 protein, ratMuc3 protein, mouseMuc3 protein, ratMucin-2Mucin-3MucinsMuscle ProteinsNeuropeptidesPeptidesRNA, MessengerTFF3 protein, ratTrefoil Factor-2Trefoil Factor-3

Identifiers

PMID10587517
PMCPMC409855
OpenAlexW2080875750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.